16 June 2016 Written by  STAT

Stem cell factory opens door for trials of personalized diabetes treatment

In a step that could lead to a new diabetes treatment, several Boston-area hospitals have teamed up with the Harvard Stem Cell Institute and biotech Semma Therapeutics to make personalized cell-based therapies and organize clinical trials.

Read the full article from STAT (HERE)